Multi-site point of care assessment of Abbott ID NOW rapid molecular test for SARS-CoV-2 in a low-prevalence setting

COVID-19 Diagnostics Research Group

doi:10.1016/j.pathol.2021.07.002

Multi-site point of care assessment of Abbott ID NOW rapid molecular test for SARS-CoV-2 in a low-prevalence setting

COVID-19 Diagnostics Research Group

Research output: Contribution to journal › Letter › peer-review

5 Citations (Scopus)

Original language	English
Pages (from-to)	912-914
Number of pages	3
Journal	Pathology
Volume	53
Issue number	7
DOIs	https://doi.org/10.1016/j.pathol.2021.07.002
Publication status	Published - Dec 2021
Externally published	Yes

Access to Document

10.1016/j.pathol.2021.07.002

Cite this

@article{2ae8ab9f842348908723ce5b743dddee,

title = "Multi-site point of care assessment of Abbott ID NOW rapid molecular test for SARS-CoV-2 in a low-prevalence setting",

author = "{COVID-19 Diagnostics Research Group} and Maryza Graham and Stephen Muhi and Tuyet Hoang and Ballard, {Susan A.} and Julie McAuley and Kwong, {Jason C.} and Williamson, {Deborah A.} and Howden, {Benjamin P.}",

year = "2021",

month = dec,

doi = "10.1016/j.pathol.2021.07.002",

language = "English",

volume = "53",

pages = "912--914",

journal = "Pathology",

issn = "0031-3025",

publisher = "Elsevier B.V.",

number = "7",

}

TY - JOUR

T1 - Multi-site point of care assessment of Abbott ID NOW rapid molecular test for SARS-CoV-2 in a low-prevalence setting

AU - COVID-19 Diagnostics Research Group

AU - Graham, Maryza

AU - Muhi, Stephen

AU - Hoang, Tuyet

AU - Ballard, Susan A.

AU - McAuley, Julie

AU - Kwong, Jason C.

AU - Williamson, Deborah A.

AU - Howden, Benjamin P.

PY - 2021/12

Y1 - 2021/12

UR - http://www.scopus.com/inward/record.url?scp=85116433756&partnerID=8YFLogxK

U2 - 10.1016/j.pathol.2021.07.002

DO - 10.1016/j.pathol.2021.07.002

M3 - Letter

C2 - 34561096

AN - SCOPUS:85116433756

SN - 0031-3025

VL - 53

SP - 912

EP - 914

JO - Pathology

JF - Pathology

IS - 7

ER -

Multi-site point of care assessment of Abbott ID NOW rapid molecular test for SARS-CoV-2 in a low-prevalence setting

Access to Document

Other files and links

Cite this